Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18769495
[patent_doc_number] => 20230364265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 18/313087
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313087
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313087 | METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION | May 4, 2023 | Pending |
Array
(
[id] => 18769496
[patent_doc_number] => 20230364266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 18/313126
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313126
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313126 | METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION | May 4, 2023 | Pending |
Array
(
[id] => 18359461
[patent_doc_number] => 20230141052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 18/157052
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18157052
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/157052 | METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION | Jan 18, 2023 | Pending |
Array
(
[id] => 18948326
[patent_doc_number] => 11891608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Immunization of large mammals with low doses of RNA
[patent_app_type] => utility
[patent_app_number] => 18/080150
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 18242
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080150
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080150 | Immunization of large mammals with low doses of RNA | Dec 12, 2022 | Issued |
Array
(
[id] => 18666517
[patent_doc_number] => 11773395
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-03
[patent_title] => Immunization of large mammals with low doses of RNA
[patent_app_type] => utility
[patent_app_number] => 18/065243
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 18245
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065243
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065243 | Immunization of large mammals with low doses of RNA | Dec 12, 2022 | Issued |
Array
(
[id] => 18309310
[patent_doc_number] => 20230113210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA
[patent_app_type] => utility
[patent_app_number] => 18/065230
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065230
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065230 | Immunisation of large mammals with low doses of RNA | Dec 12, 2022 | Issued |
Array
(
[id] => 18325803
[patent_doc_number] => 20230123931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA
[patent_app_type] => utility
[patent_app_number] => 18/065256
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065256 | Immunisation of large mammals with low doses of RNA | Dec 12, 2022 | Issued |
Array
(
[id] => 18307769
[patent_doc_number] => 20230111669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA
[patent_app_type] => utility
[patent_app_number] => 18/080164
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080164
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080164 | Immunisation of large mammals with low doses of RNA | Dec 12, 2022 | Issued |
Array
(
[id] => 18854097
[patent_doc_number] => 11851660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Immunisation of large mammals with low doses of RNA
[patent_app_type] => utility
[patent_app_number] => 18/065267
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 18217
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065267
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065267 | Immunisation of large mammals with low doses of RNA | Dec 12, 2022 | Issued |
Array
(
[id] => 18581576
[patent_doc_number] => 20230263828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE
[patent_app_type] => utility
[patent_app_number] => 18/054521
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054521
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054521 | Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence | Nov 9, 2022 | Issued |
Array
(
[id] => 19134595
[patent_doc_number] => 11969504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Non-naturally occurring vesicles comprising a chimeric vesicle localization moiety, methods of making and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/888862
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 34398
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888862 | Non-naturally occurring vesicles comprising a chimeric vesicle localization moiety, methods of making and uses thereof | Aug 15, 2022 | Issued |
Array
(
[id] => 18093476
[patent_doc_number] => 20220411817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 17/855423
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855423 | METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION | Jun 29, 2022 | Abandoned |
Array
(
[id] => 18005344
[patent_doc_number] => 20220364110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 17/855230
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855230
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855230 | METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION | Jun 29, 2022 | Abandoned |
Array
(
[id] => 17850506
[patent_doc_number] => 20220280547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING LONG COVID
[patent_app_type] => utility
[patent_app_number] => 17/745723
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745723 | COMPOSITIONS AND METHODS FOR TREATING LONG COVID | May 15, 2022 | Pending |
Array
(
[id] => 17836515
[patent_doc_number] => 20220273820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => RNA CONSTRUCTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/565921
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/565921 | RNA constructs and uses thereof | Dec 29, 2021 | Issued |
Array
(
[id] => 17593495
[patent_doc_number] => 20220143068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => RNA AND NUCLEIC ACID CARRIER INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/533533
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533533 | RNA and nucleic acid carrier including the same | Nov 22, 2021 | Issued |
Array
(
[id] => 18207921
[patent_doc_number] => 20230054178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TREM COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/519120
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17519120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/519120 | TREM compositions and uses thereof | Nov 3, 2021 | Issued |
Array
(
[id] => 17428741
[patent_doc_number] => 20220056449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA
[patent_app_type] => utility
[patent_app_number] => 17/512258
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512258 | Immunisation of large mammals with low doses of RNA | Oct 26, 2021 | Issued |
Array
(
[id] => 18228490
[patent_doc_number] => 20230067484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 17/499232
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499232
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499232 | Methods and compositions for genomic integration | Oct 11, 2021 | Issued |
Array
(
[id] => 17996687
[patent_doc_number] => 11497773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
[patent_app_type] => utility
[patent_app_number] => 17/493280
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 87
[patent_no_of_words] => 49296
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493280 | Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence | Oct 3, 2021 | Issued |